Recent advances in the genetics of Alzheimer's disease

Journal of Geriatric Psychiatry and Neurology

Volumn 11, Issue 2, 1998, Pages 42-54

  Levy Lahad, Ephrat ^a   Tsuang, Debby ^a   Bird, Thomas D ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; PRESENILIN 1; PRESENILIN 2;

ALZHEIMER DISEASE; CHROMOSOME 1; CHROMOSOME 14; CHROMOSOME 19; CHROMOSOME 21; FAMILIAL DISEASE; GENE MUTATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; ONSET AGE; PRIORITY JOURNAL; REVIEW;

EID: 0032420923     PISSN: 08919887     EISSN: None     Source Type: Journal    
DOI: 10.1177/089198879801100202     Document Type: Review

References (170)

1. Larson EB, Kukull WA, Katzman RL. Cognitive impairment, dementia and Alzheimer's disease. Anna Rev Public Health 1992; 13:431-439.
2. Hofman A, Rocca WA, Brayne C, et al. The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Int JEpidemiol 1931; 20:736-748.
3. Hirst C, Yee IML, Sadovnick AD. Familial risk for Alzheimer disease from a population based series. Genet Epidemiol 1996; 11:365-374.
4. Hocking LB, Breitner JCS. Cumulative risk of Alzheimerlike dementia in relatives of autopsy-confirmed cases of Alzheimer's disease. Dementia 1995; 6:355-356.
5. Bierer L, Silverman J, Mobs R, et al. Morbid risk to first degree relatives of neuropathologically confirmed cases of Alzheimer's disease. Dementia. 1992; 3:134-139.
6. Farrar L, Cupples LA, van Duijn CM, et al. Apolipoprotein E genotype in patients with Alzheimer's disease: implications for risk of dementia among relatives. Ann Neurol 1995; 38:797-808.
7. Mohs R, Breitner J, Silverman J, et al. Alzheimer's diseasemorbid risk among first degree relatives approximates 50% by 90 years of age. Arch Gen Psychiatry 1987; 44:405-408.
8. Mann DMA. Association between Alzheimer's disease and Down syndrome: neuropathological observations. In: Berg JM, Karlinsky J, Holland AJ, eds. Alzheimer disease, Down syndrome, and their relationship. Oxford, UK: Oxford University Press, 1993:71-92.
9. Cook RH, Ward BE, Austin JH. Studies in aging of the brain: IV. Familial Alzheimer disease: relation to transmissible dementia, aneuploidy, and microtubular defects. Neurology 1979; 29:1402-1412.
10. Nee LE, Polinsky RJ, Eldridge R, et al. A family with histologically confirmed Alzheimer's disease. Arch Neurol 1983; 40:203-208.
11. Foncin JF, Salmon D, Supino-Viterbo V, et al. Démence Presenile D'Alzheimer transmise dans une famille étundue. Rev Neurol (Paris) 1985; 141:194-202.
12. Bird TD, Sumi SM, Nemens EJ, et al. Phenotypic heterogeneity in familial Alzheimer's disease: a study of 24 kindreds. Ann Neurol 1989; 24:12-25.
13. Goudsmit JAAP, White BJ, Weitkamp LR, et al. Familial Alzheimer's disease in two kindreds of the same geographic and ethnic origin. J Neurol Sci 1981; 49:79-89.
14. Martin JHJ, Bruyland M, Gras P, et al. Early-onset Alzheimer's disease in 2 large Belgian families. Neurology 1991; 41:62-68.
15. Goate AM, Chartier-Harlene CM, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 353:844-846.
16. Sherrington R, Rogaev El, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1991; 375:754-760.
17. Levy-Lahad E, Wasco W, Poorkaj P, et al. A candidate for the chromosome 1 familial Alzheimer's disease locus. Science 1995; 269:973-977.
18. Stritmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E; high avidity binding to beta amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993; 90:1977-1981.
19. Corder EH, Saunders AM, Stritmatter WJ, et al. Gene dose of the apolipoproteinE type-4 allele and the risk of Alzheimer's disease in late-onset families. Science 1993; 261:921-923.
20. Levy-Lahad E, Bird TD. Genetic factors in Alzheimer's disease: a review of recent advances. Ann Neurol 1996; 40:829-840.
21. Rang J, Lemaire HG, Unterbeck A, et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987; 325:733-736.
22. Glenner GG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984; 120:885-890.
23. Lemaire HG, Salbaum JM, Multhaup G, et al. The preA4 695 precursor protein of Alzheimer's disease A4 amyloid in encoded by 16 exons. Nucleic Acids Res 1989; 17:517-522.
24. Tanzi RE, Gusella JF, Watkins PC, et al. Amyloid-protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 1987; 235:880-884.
25. Rumble B, Retallak R, Hilbich G, et al. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med 1989; 320:1446-1452.
26. Naruse S, Igarashi S, Aoki K, et al. Mis-sense mutation Val He in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease. Lancet 1991; 337:978-979.
27. Karlinsky H, Vaula G, Haines JL, et al. Molecular and prospective phenotypic characterization of a pedigree with familial Alzheimer's disease and a missense mutation in codon 717 of the -amyloid precursor protein gene. Neurology 1992; 42:1445-1453.
28. Fidani L, Rooke K, Chartier-Harlin M, et al. Screening for mutations in the open reading frame and promoter of the beta-amyloid precursor protein gene in familial Alzheimer's disease: identification of a further family with APP 717 Val lia Hum Mol Genet 1992; 1:165-168.
29. Murrell J, Farlow M, Ghetti B, Benson MD. A mutation in the amyloid precursor protein associated with presenile dementia. Science 1991; 254:94-99.
30. Chartier-Harlin CM, Crawford F, Houlden H, et al. Early-onset Alzheimer's disease caused by a mutation in codon 717 of the beta-amyloid precursor protein gene. Nature 1991; 353:844-846.
31. Mullan M, Crawford F, Axelman K, et al. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet 1992; 1:345-347.
32. Eckman CB, Mehta ND, Crook R, et al. A new pathogenic mutation in the APP gene (1716V) increases the relative proportion of A beta 42(43). Hum Mol Genet 1997; 6:2087-2089.
33. Hendriks L, Van Duijn C, Crass P, et al. Presenile dementia and cerebral hemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet 1992; 1:218-221.
34. Levy E, Carman MD, Fernandez-Madrid IJ, et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 1990; 248:1124-1126.
35. St. George-Hyslop PH, Tanzi RE, Polinsky RJ, et al. The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science 1987; 235:885-890.
36. St. George-Hyslop PH, Haines JL, Farrar LA, et al. Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder. Nature 1990; 347:194-197.
37. Schellenberg GD, Bird TD, Wijsman EM, et al. Absence of linkage of chromosome 21q21 markers to familial Alzheimers disease. Science 1988; 241:1507-1510.
38. Pericak-Vance MA, Yamaoka LH, Haynes CS, et al. Genetic linkage studies in Alzheimer's disease families. Exp Neurol 1988; 102:271-279.
39. Kamino K, Orr TH, Payami H, et al. Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region. Am J Hum Genet 1992; 51:998-1014.
40. Evenhuis HM. The natural history of dementia in Down's Syndrome. Arch Neurol 1990; 47:263-276.
41. Sisodia SS, Koo EH, Beyruther K, et al. Evidence that amyloid protein in Alzheimer's disease is not derived by normal processing. Science 1990; 248:492-495.
42. Haass C, Scholssmacher MG, Hung AY, et al. Amyloid beta peptide is produced by cultured cell during normal metabolism. Nature 1992; 359:322-325.
43. Seubert P, Vigo-Pelfrey C, Esch F, et al. Isolation and quantitation of soluble Alzheimer's beta peptide from biological fluids. Nature 1992; 359:325-327.
44. Cai XD, Golde TE, Younkin SG. Release of excess beta-amyloid beta protein from a mutant amyloid beta protein precursor. Science 1993; 259:514-516.
45. Citron M, Oltersdorf T, Haass G, et al. Mutation of the beta amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 1992; 360:672-674.
46. Haass C, Hung AY, Selkoe DJ, Teplow DB. Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor. J Biol Chem 1994; 269:1-8.
47. Citron M, Vego-Pelfrey C, Teplow DB, et al. Excessive production of amyloid beta protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer's disease mutation. Proc Natl Acad Sci USA 1994; 91:11393-11997.
48. Suzuki N, Cheung TT, Cai XD, et al. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (APP717) mutants. Science 1994; 264:1336-1340.
49. Tamaoka A, Odaka A, Ishibashi Y, et al. APP 717 missense mutation affects the ratio of amyloid beta protein species in familial Alzheimer's disease brain. J Biol Chem 1994; 269:32721-32724.
50. Jarrett JT, Lansbury PT Seeding 'one dimensional crystallization'of amyloid: a pathogenic mechanism in Alzheimer disease and scrapie? Cell 1993; 73:1055-1058.
51. Yamatsuji T, Matsui T, Okamoto T, et al. G protein-mediated neuronal DNA fragmentation induced by familial Alzheimer's disease-associated mutants of APP. Science 1996; 272:1343-1352.
52. Hsiao K, Chapman P, Nilsen S, et al. Correlative memory deficits, A elevation, and amyloid plaques in transgenic mice. Science 1996; 274:99-102.
53. Schellenberg GD, Bird TD, Wijsman EM, et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 1992; 258:668-671.
54. St. George-Hyslop P, Haines J, Rogaev E, et al. Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nat Genet 1992; 2:330-334.
55. Van Broeckhoven C, Backhovens H, Cruts M, et al. Mapping of a gene predisposing to early-onset Alzheimer's disease to chromosome 14q24.3. Nat Genet 1992; 2:335-339.
56. Mullan M, Houlden H, Windelspecht M, et al. A locus for familial early-onset Alzheimer's disease maps to the long arm of chromosome 14, proximal to the alphal-antichymotrypsin gene. Nat Genet 1992; 2:340-342.
57. Alzheimer's Disease Collaborative Group. The structure of the presenilin l (S182) gene and identification of six novel mutations in early onset AD families. Nat Genet 1995; 11:219-222.
58. Sahara A, YahagiY, Hideyuki T, et al. Identification and characterization of presenilin 1-467,1-463 and 1-374. FEES Lett 1996; 381:7-11.
59. Rogaev El, Sherrington R, Rogaeva E, et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995; 376:775-778.
60. Chapman J, Asherov A, Wang N, et al. Familial Alzheimer's disease associated with S182 codon 286 mutation. Lancet 1996; 346:1040.
61. Campion D, Flaman J-M, Brice A. Mutations of the presenilin I gene in families with early-onset Alzheimer's disease. Hum Mol Genet 1995; 4:2373-2377.
62. Cervenakova L, Brown P, Kenney K Identification of AD3 gene point mutations in three early-onset Alzheimer's disease families. Neurology 1995; 46:A249.
63. Sorbi S, Nacmias B, Forleo P, et al. Missense mutation of S182 in Italian families with early-onset Alzheimer's disease. Lancet 1996; 346:439-440.
64. Tanahashi H, Mitsunaga Y, Takahashi K, et al. Missense mutation of S182 gene in Japanese familial Alzheimer's disease. Lancet 1995; 346:440.
65. Wasco W, Pettingel WP, Jondro PD, et al. Familial Alzheimer's disease chromosome 14 mutations. Nat Med 1995; 1:848.
66. Cruts M, Van Broeckhoven C. Presenilin mutations in Alzheimer's disease. Hum Mutât 1998; 11:183-190.
67. Perez-Tur J, Froelich S, Prihar G, et al. A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene. Neuroreport 1995; 7:297-301.
68. Lampe TH, Bird TD, Nochlin D, et al. Phenotype of chromosome 14-linked familial Alzheimer's disease in a large kindred. Ann Neurol 1994; 36:368-378.
69. Bird TD, Lampe TH, Nemens EJ, et al. Familial Alzheimer's disease in American descendants of the Volga Germans: probable genetic founder effect. Ann Neurol 1988; 23:25-31.
70. Bird TD, Nemens EM, Nochlin D, et al. Familial Alzheimer's disease in Germans from Russia: a model of genetic heterogeneity in Alzheimer's disease. In: Boiler F, et al, eds. Heterogeneity of Alzheimer's disease. Berlin: Springer-Verlag, 1992:118-129.
71. Levy-Lahad E, Wijsman EM, Nemens E, et al. A familial Alzheimer's disease locus on chromosome 1. Science 1995; 269:970-973.
72. Levy-Lahad E, Poorkaj P, Wang K, Mulligan J, et al. Genomic structure and expression of STM2, the chromosome 1 familial Alzheimer's disease gene. Genomics 1996; 34:198-204.
73. Cruts M, van Duijn CM, Backhovens H, et al. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet 1998; 7:43-51.
74. Beyer K, Lao JI, Fernandez-Novoa L, Cacabelos R. Identification of a novel mutation (V148I) in the TM2 domain of the presenilin 2 gene in a patient with late-onset Alzheimer disease [abstract]. Neurobiol Aging 1998; 19:887.
75. Bird TD, Levy-Lahad E, Poorkaj P, et al. Wide range in ageof-onset for chromosome 1 related familial Alzheimer's disease. Ann Neurol 1996; 40:932-935.
76. Schellenberg G, Payami H, Wijsman E, et al. Chromosome 14 and late onset familial Alzheimer's disease. Am JHum Genet , 1993; 53:619-628.
77. Wragg M, Hutton M, Talbot C, the Alzheimer's Disease Collaborative Group. Genetic association between intronic poly- ' morphism in the presenilin-1 gene and late-onset Alzheimer's disease. Lancet 1996; 347:509-512.
78. Keho P, Williams J, Lovestone S, et al. Presenilin-1 polymor- t phism and Alzheimer's disease. Lancet 1996; 347:1185-1186.
79. Higuchi S, Muramatsu T, Matsushita S, et al. Presenilin-1 polymorphism and Alzheimer's disease. Lancet 1996; 347:1186.
80. Scott WK, Growdon JH, Roses AD, et al. Presenilin-1 polymorphism and Alzheimer's disease. Lancet 1996; ' 347:1186-1187.
81. Kovacs DM, Fausett HJ, Page KJ, et al. Alzheimer-associated ) presenilins 1 and 2: neuronal expression in the brain and localization to intracellular membranes in mammalian cells. Nat Med 1996; 2:224-229.
82. McMillan PJ, Leverenz JB, Poorkaj P, et al. Neuronal expression of STM2 mRNA in human brain is reduced in Alzheimer's disease. J Histochem Cytochem 1996; 44:1215-1222.
83. Levitan D, Greenwald I. Facilitation of lin-12-mediated signaling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 1995; 377:351-354.
84. L'Hernault SW, Arduengo PM. Mutation of a putative sperm membrane protein in Caenorhabditis elegans prevents sperm differentiation but not its associated meiotic divisions. J Cell Biol 1995; 119:55-68.
85. Scheuner D, Eckman G, Jensen M, et al. The amyloid pro- , tein deposited in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 1996; 2:864-870.
86. Smale G, Nichols NR, Brady DR, et al. Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol 1995; 133:225-230.
87. Loo DT, Copani C J, Pike ER. Apoptosis is induced by -amyloid in cultured central nervous system neurons. Proc Natl Acad Sci USA 1993; 99:7351-7355.
88. Busciglio J, Yankner B. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 1995; 378:776-779.
89. Vito P, Lacana E, D'Adamio L. Interfering with apoptosis: Ca+2 binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science 1996; 271:521-525.
90. Duff K, Eckman C, Zehr G, et al. Increased amyloid-beta 42(43) in brains of mice expressing mutant presenilin 1. Nature 1996; 383:710-713.
91. Shen J, Bronson RT, Chen DF, et al. Skeletal and CNS defects in presenilin-1-deficient mice. Cell 1997; 89:629-639.
92. Citron M, Westaway D, Xia \V, et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid -protein in both transfected cells and transgenic mice. Nat Med 1997; 3:67-72.
93. Borchelt DR, Ratovitski T, van Lare J, et al. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 1997; 19:939-945.
94. Holcomb L, Gordon MM, McGowan E, et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 1998; 4:97-100.
95. Bird TD, Bennett RL. Why do DNA testing? Practical and ethical implications of new neurogenetic tests. Ann Neurol 1995; 38:141-146.
96. Lannfelt L, Axelman K, Lilius L, Basun H. Genetic counseling in a Swedish Alzheimer family with amyloid precursor protein mutation. Am J Hum Genet 1995; 56:332-335.
97. Bennett RL, Bird TD, Teri L. Offering predictive testing for Huntington's disease in a medical genetics clinic. J Genet Counseling 1993; 2:123-137.
98. Pericak-Vance MA, Bebout JL, Gaskell PC, et al. Linkage studies in familial Alzheimer's disease: evidence for chromosome 19 linkage. Am J Hum Genet 1991; 41:1034-1050.
99. Schellenberg GD, Deeb SS, Boehnke M, et al. Association of an apolipoprotein CII allele with familial dementia of the Alzheimer type. JNeurogenet 1987; 4:97-108.
100. Namba Y, Tomonaga M, Kawasaki H, et al. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeld-Jakob disease. Brain Res 1991; 641:163-166.
101. Saunders AM, Stritmatter WJ, Schmechel D, et al. Association of the apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43:1467-1472.
102. Yu CE, Payami H, Oison JM, et al. The apolipoprotein E/CI/CII gene cluster and late-onset Alzheimer's disease. Am J Hum Genet 1994; 54:631-642.
103. Rebeck GW, Reiter JS, Stirckland DK. Apolipoprotein E in sporadic Alzheimer's disease: allelic variations and receptor interactions. Neuron 1993; 11:575-580.
104. Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein e4 allele in patients with Alzheimer's disease. Ann Neurol 1993; 34:752-754.
105. Tsai MS, Tsangalos EG, Petersen RC. Apolipoprotein E: risk factor for Alzheimer's disease. Am J Hum Genet 1994; 54:643-649.
106. Van Duijn CM, de Kniff P, Cruts M, et al. Apolipoprotein e4 allele in a population based study of early-onset Alzheimer's disease. Nat Genet 1994; 7:74-78.
107. Perez-Tur J, Campion D, Martinez M, et al. Evidence for apolipoprotein e4 association in early-onset Alzheimer's patients with late-onset relatives. Am J Med Genet 1995; 60:550-553.
108. Fairer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. JAMA 1997; 278:1349-1356.
109. Jarvik GP, Larson EB, Goddard K, et al. Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample. Am J Hum Genet 1996; 58:191-200.
110. Poirier J, Davignon J, Bouthillier D, et al. Apolipoprotein E polymorphisms and Alzheimer's disease. Lancet 1993; 342:697-699.
111. Corder EH, Saunders AM, Risch NJ. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 1994; 7:180-184.
112. Lucotte G, Aouzirate A, Gerard N, et al. Allele doses of apolipoprotein E type e4 in sporadic late-onset Alzheimer's disease. Am JMed Genet 1995; 60:566-569.
113. Payami H, Montée KR, Kaye JA, et al. Alzheimer's disease, apolipoprotein E e4 and gender. JAMA 1994; 271:1316-1317.
114. Fairer LA, Cupples LA, van Duijn CM. Apolipoprotein E genotype in patients with Alzheimer's disease: implications for the risk of dementia among relatives. Ann Neurol 1995; 38:797-808.
115. Tsuda T, Lopez R, Rogaeva EA, et al. Are the associations between Alzheimer's disease and the polymorphisms in the apolipoprotein E and the apolipoprotein CII genes due to linkage disequilibrium? An Neurol 1994; 36:97-100.
116. Talbot C, Lendon C, Craddock N, et al. Protection against Alzheimer's disease with ApoE e2. Lancet 1994; 343:1432-1433.
117. Maestre G, Ottman R, Stern Y, et al. Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol 1995; 37:254-259.
118. Tang MX, Maestre G, Tsai W-Y, et al. Relative risk of Alzheimer's disease and age-at-onset distributions, based on ApoE genotypes among elderly AfricanAmericans, Caucasians and Hispanics in New York City. Am J Hum Genet 1996; 58:574-584.
119. van Duijn CM, de Knijff P, Wehnert A, et al. The apolipoprotein E e2 allele is associated with an increased risk of early onset Alzheimer's disease and a reduced survival. Ann Neurol 1995; 37:605-610.
120. Sorbi S, Nacmias B, Forleo P, et al. ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease. Neurosci Lett 1994; 177:100-102.
121. Noguchi S, Murakami K, NobuhiroY. Apolipoprotein E genotype and Alzheimer's disease. Lancet 1993; 324:737.
122. Hendrie HC, Hall KS, Hui S, et al. Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans. Ann Neurol 1995; 37:118-120.
123. St. George-Hyslop P, McLachlan DC, Tuda T, et al. Alzheimer's disease and possible gene interaction. Science 1994; 263:537.
124. Alzheimer's Disease Collaborative Group. Apolipoprotein E genotype and Alzheimer's disease. Lancet 1993; 342:738-739.
125. Nacmias B, Latorraca S, Piersanti P, et al. ApoE genotype and familial Alzheimer's disease: a possible influence on age-of-onset in APP Val - 12 Ile mutated families. Neurosci Lett 1935; 183:1-3.
126. Sorbi S, Nacmias B, Forleo P, et al. Epistatic effect of APP717 mutation and apolipoprotein E genotype in familial Alzheimer's disease. Ann Neurol 1995; 38:124-127.
127. Brooks WS, Martins RM, De Voecht J, et al. A mutation in codon 717 of the amyloid precursor gene in an Australian family with Alzheimer's disease. Neurosci Lett 1995; 199:183-186.
128. Haan J, Van Broeckhoven C, van Duijn CM, et al. The apolipoprotein E e4 allele does not influence the clinical expression of the amyloid precursor protein gene codon 693 and 692 mutation. Ann Neurol 1994; 36:434-37.
129. Van Broeckhoven C, Backhovens H, Cruts M, et al. ApoE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease. Neurosci Lett 1994; 169:179-180.
130. Levy-Lahad E, Lahad A, Wijsman EM, et al. Apolipoprotcin E genotypes and early-onset familial Alzheimer's disease. Ann Neurol 1995; 38:679-680.
131. van Gool WA, Evenhuis HM, van Duijn CM, for the Dutch Study Group on Down's Syndrome and Aging. A case-control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. Ann Neurol 1995; 38:225-230.
132. Schupf N, Kappel D, Zigman W, et al. Dementia and decline in adaptive competence is associated with ApoE e4 in Down's syndrome. Neurology 1996; 46:A419.
133. Schupf N, Kapeil D, Nightingale B, et al. Earlier onset of Alzheimer's disease in men with Down syndrome. Neurology 1998; 50:991-995.
134. Jarvik GP, Wijsman EM, Kukul WA, et al. Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study. Neurology 1995; 45:1092-1096.
135. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer Disease. Statement on use of apolipoprotein E testing for Alzheimer's disease. JAMA 1995; 274:1627-1629.
136. Myers RH, Schaefer EJ, Wilson PWF, et al. Apolipoprotein E s4 association with dementia in a population-based study: The Framingham Study. Neurology 1996; 46:673-677.
137. Blacker D, Haines JL, Rodes L, et al. ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative. Neurology 1997; 48:139-147.
138. Mayeux R, Saunders AM, Shea S, et al. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. NEnglJMed 1998; 338:506-511.
139. Galasko D, Saitoh T, Xia Y, et al. The apolipoprotein allele e4 is overrepresented in patients with Lewy body variant of Alzheimer's disease. Neurology 1994; 44:950-951.
140. Schneider JA, Gearing M, Robbins RS, et al. Apolipoprotein E genotyping in diverse neurodegenerative disorders. Ann Neurol 1995; 38:131-135.
141. Gustafson L, Abrahamson M, Grubb A, et al. ApolipoproteinE genotyping in Alzheimer's disease and frontotemporal dementia. Dement Geriatr Cogn Disord 1997; 8:240-243.
142. Frisoni GB, Bianchetti A, Govoni S.Association of apolipoprotein E e4 with vascular dementia. JAMA 1994; 271:1317.
143. Isoe K, Urakami K, Sate K, et al. Apolipoprotein E in patients with dementia of the Alzheimer type and vascular dementia. Acta Neurol Scand 1996; 93:133-137.
144. Bird TD. Apolipoprotein E genotyping in the diagnosis of Alzheimer's disease: a cautionary view. Ann Neurol 1995; 38:317-318.
145. National Institute on Aging/Alzheimer's Association Working Group. Apolipoprotein E genotyping in Alzheimer's disease. Lancet 1996; 347:1091-1095.
146. Roses RD. Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Ann Neurol 1995; 38:6-14.
147. Poirier J, Delisle M-C, Quirion R, et al. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc Natl Acad Sci USA 1995; 92:12260-12264.
148. Reiman EM, Caselli RJ, Yun LS, et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the e4 allele for apolipoprotein E. N Engl J Med 1996; 334:759-762.
149. Schmechel DE, Saunders AM, Strittmatter WJ, et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of ApoE genotype in late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1993; 90:9649-9653.
150. Strittmatter WJ, Saunders AM, Schmechel D, et al. Binding of human apolipoprotein E to A4 peptide: isoform specific effects and implications for late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1993; 90:8098-8102.
151. Sana DA, Weisgraber KH, Russell SJ, et al. Apolipoprotein E associates with amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform ApoE4 associates more efficiently than ApoES. J Clin Invest 1994; 94:860-869.
152. LaDu MJ, Falduto MT, Manelli AM, et al. Isoform specific binding of apolipoprotein E to -amyloid. J Biol Chem 1994; 269:23403-23406.
153. Bales KR, Verina T, Dodel RC, et al. Lack of apolipoprotein E dramatically reduces amyloid -peptide deposition. Nat Genet 1997; 17:263-264.
154. Strittmatter WJ, Saunders AM, Goedert M, et al. Isoform-specific interactions of apolipoprotein E with microtubule associated protein tau: implications for Alzheimer's disease. Proc Natl Acad Sci USA 1994; 91:11183-11186.
155. Gomez-Isla T, West HL, Rebeck GW, et al. Clinical and pathological correlates of apolipoprotein E e4 in Alzheimer's disease. Ann Neurol 1996; 39:62-70.
156. Minthon L, Hesse G, Sjeogren M, et al. The apolipoprotein E epsilon-4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease. Neurosci Lett 1997; 226:65-67.
157. Stevens M, van Duijn CM, de Kniff P, et al. Apolipoprotein E gene and sporadic frontal lobe dementia. Neurology 1997; 48:1526-1529.
158. Stevens M, van Duijn CM, Kamphorst W, et al. Familial aggregation in frontotemporal dementia. Neurology 1998; 50:1541-1545.
159. Tsuang D, Raskind MA, Leverenz J, et al. The effect of apolipoprotein E genotype on expression of an autosomal dominant schizophreniform disorder with progressive dementia and neurofîbrillary tangles. Biol Psychiatr 1997; 41:191-195.
160. Poirier J. Apolipoprotein E in animal models of CNS injury and Alzheimer's disease. Trends Neurosci 1994; 17:525-530.
161. Pericak-Vance MA, Bass MP, Yamaoka LH, et al. Complete genomic screen in late-onset familial Alzheimer disease. JAMA 1997; 278:1237-1241.
162. Rogaeva E, Premkumar S, Song Y, et al. Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity. JAMA 1998; 280:614-618.
163. Wu WS, Holmans P, Wavrant-DeVrieze F, et al. Genetic studies on chromosome 12 in late-onset Alzheimer disease. JAMA 1998; 280:619-622.
164. Blacker D, Wilcox MA, Laird NM, et al. Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat Genet 1998; 19:357-360.
165. Fagan AM, Bu G, Sun Y, et al. Apolipoprotein E-containing high density lipoprotein promotes neunte outgrowth and is a ligand for the low density lipoprotein receptor-related protein. JBiol Chem 1996; 271:30121-30125.
166. Kounnas MZ, Moir RD, Rebeck GW, et al. LDL receptorrelated protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation. Cell 1995; 82:331-340.
167. Wavrant-DeVrieze F, Perez-Tur J, Lambert JC, et al. Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease. Neurosci Lett 1997; 227:68-70.
168. Lendon CL, Talbot CJ, Craddock NJ, et al. Genetic association studies between dementia of the Alzheimer's type and three receptors for apolipoprotein E in a Caucasian population. Neurosci Lett 1997; 222:187-190.
169. Kang DE, Saitoh T, Chen X, et al. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology 1997; 49:56-61.
170. Scott WK, Yamaoka LH, Pritchard ML, et al. No genetic association between LRP receptor and sporadic or late-onset Alzheimer disease. Neurogenetics (in press).